MediumEndocrinologyType 2 diabetes with chronic kidney diseaseca-mccqe1ca-rcpsc-im
A 72-year-old man with long-standing poorly controlled type 2 diabetes and chronic kidney disease (eGFR 35 mL/min/1.73 m²) presents with progressive fatigue and ankle oedema. His HbA1c is 6.8% on basal insulin and a sulfonylurea. According to Diabetes Canada and nephrology guidance, which antihyperglycaemic adjustment is most appropriate?